Serotonin and Mental Disorders: A Concise Review on Molecular Neuroimaging Evidence.
10.9758/cpn.2014.12.3.196
- Author:
Shih Hsien LIN
1
;
Lan Ting LEE
;
Yen Kuang YANG
Author Information
1. Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. bce2369@hotmail.com
- Publication Type:Review
- Keywords:
Serotonin;
Mental disorders;
Positron-emission tomography;
Single photon emission computed tomography
- MeSH:
Anxiety Disorders;
Attention Deficit Disorder with Hyperactivity;
Autistic Disorder;
Depressive Disorder, Major;
Functional Neuroimaging;
Mental Disorders*;
Mental Health;
Mood Disorders;
Neuroimaging*;
Neurotransmitter Agents;
Positron-Emission Tomography;
Schizophrenia;
Serotonin*;
Tomography, Emission-Computed, Single-Photon
- From:Clinical Psychopharmacology and Neuroscience
2014;12(3):196-202
- CountryRepublic of Korea
- Language:English
-
Abstract:
Serotonin is one of the most important neurotransmitters influencing mental health and, thus, is a potential target for pharmaco-logical treatments. Functional neuroimaging techniques, such as positron-emission tomography (PET) and single photon emission computed tomography (SPECT), could provide persuasive evidence for the association between mental disorders and serotonin. In this concise review, we focus on evidence of the links between serotonin and major depressive disorders, as well as other mood disorders, anxiety disorders, schizophrenia, addiction, attention deficit hyperactivity disorder (ADHD), and autism.
